15,000 Shares in Roche Holding AG $RHHBY Bought by Corient IA LLC

Key Points

• Corient IA LLC has acquired a new stake in Roche Holding AG, purchasing 15,000 shares valued at approximately $616,000 during the first quarter.
• Multiple institutional investors, including Fulton Bank N.A. and PNC Financial Services Group Inc., have recently adjusted their holdings in Roche, indicating increased interest in the stock.
• Roche's stock currently has an average rating of "Moderate Buy" according to analyst reports, following recent downgrades from HSBC from a "buy" to a "hold" rating.

Corient IA LLC purchased a new position in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 15,000 shares of the company's stock, valued at approximately $616,000.

Other large investors have also bought and sold shares of the company. Altrius Capital Management Inc grew its position in Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after acquiring an additional 6,545 shares during the last quarter. Hancock Whitney Corp grew its position in Roche by 6.8% during the 4th quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after acquiring an additional 1,496 shares during the last quarter. Everett Harris & Co. CA bought a new stake in Roche during the 1st quarter worth approximately $445,000. Bard Financial Services Inc. grew its position in Roche by 25.3% during the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after acquiring an additional 28,050 shares during the last quarter. Finally, Rhumbline Advisers grew its position in Roche by 7.4% during the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after acquiring an additional 7,374 shares during the last quarter.

Roche Stock Down 0.7%

Shares of RHHBY stock traded down $0.30 during trading hours on Thursday, reaching $40.45. The company had a trading volume of 1,196,009 shares, compared to its average volume of 2,297,270. The company has a 50 day moving average of $40.03 and a 200 day moving average of $40.27. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.20 and a current ratio of 1.48. Roche Holding AG has a 1-year low of $34.1030 and a 1-year high of $44.31.

Analyst Ratings Changes

RHHBY has been the topic of several research reports. Hsbc Global Res downgraded Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. HSBC downgraded Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy".

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.